1. Home
  2. VECO vs HRMY Comparison

VECO vs HRMY Comparison

Compare VECO & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veeco Instruments Inc.

VECO

Veeco Instruments Inc.

HOLD

Current Price

$32.56

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$36.69

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VECO
HRMY
Founded
1945
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
VECO
HRMY
Price
$32.56
$36.69
Analyst Decision
Buy
Strong Buy
Analyst Count
6
9
Target Price
$28.00
$51.33
AVG Volume (30 Days)
552.1K
691.5K
Earning Date
02-11-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.44
EPS
0.83
3.17
Revenue
$681,408,000.00
$825,944,000.00
Revenue This Year
N/A
$23.11
Revenue Next Year
$9.65
$16.15
P/E Ratio
$37.40
$11.60
Revenue Growth
N/A
21.13
52 Week Low
$16.92
$25.52
52 Week High
$34.45
$40.93

Technical Indicators

Market Signals
Indicator
VECO
HRMY
Relative Strength Index (RSI) 67.77 46.46
Support Level $28.46 $35.42
Resistance Level $29.58 $37.79
Average True Range (ATR) 1.02 1.04
MACD 0.20 -0.46
Stochastic Oscillator 93.59 30.38

Price Performance

Historical Comparison
VECO
HRMY

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: